Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deoxynivalenol
(
DON
) is a common mycotoxin produced by Fusarium sp. in cereals and foods. Ingestion of contaminated foodstuffs can cause digestive disorders in various animals. Many researchers focus on its toxicity and the pathological damage and absorptive function in the intestines. However, the effect of
DON
on gastric function is still unclear. The objective of the current study was to evaluate the impact of
DON
on gastric secretion. Rats were gavaged with
DON
at the dose of 0, 1, 5, and 25 mg/kg of body weight (bw). Gastric fluids were gathered by pylorus ligation 0.5 h after
DON
exposure. The results indicate that the volume of gastric fluid decreased by 25, 51, and 61% compared with the control, respectively. The pH increased to 3.2, 3.81, and 6.65 in the 1, 5, and 25 mg/kg bw
DON
group, compared with the control (1.9). To examine the mucosal injuries, the stomach tissues were made into hematoxylin and eosin slides. Histopathology observations suggest that no mucosal lesions were observed until
DON
exposure at 25 mg/kg bw. Additionally, the
gastrin
secretion in the fluids and mRNA expression in tissues were determined by the radioimmunoassay and real-time PCR assay, respectively. The results indicated that both significantly decreased in
DON
-exposed rats compared with the control. Taken together,
DON
exposure reduced gastric secretion in rats. Low
gastrin
secretion and mRNA expression play a major role, unless mucosal lesions by high
DON
exposure are present.
...
PMID:Inhibitory effects of deoxynivalenol on gastric secretion in rats. 2519 99